89 related articles for article (PubMed ID: 3902662)
21. Lymphoproliferative responses of leprosy patients and healthy controls to nitrocellulose-bound M. leprae antigens.
Sachdeva G; Kaur G; Bhutani LK; Bamezai RN
Int J Lepr Other Mycobact Dis; 1999 Jun; 67(2):133-42. PubMed ID: 10472365
[TBL] [Abstract][Full Text] [Related]
22. Antigenic heterogeneity in patients with reactions in borderline leprosy.
Barnetson RS; Bjune G; Pearson JM; Kronvall G
Br Med J; 1975 Nov; 4(5994):435-7. PubMed ID: 53086
[TBL] [Abstract][Full Text] [Related]
23. The suppressive effect of M. leprae on the in vitro proliferative responses of lymphocytes from patients with leprosy.
Nath I; Singh R
Clin Exp Immunol; 1980 Sep; 41(3):406-14. PubMed ID: 7002396
[TBL] [Abstract][Full Text] [Related]
24. Rational combination of peptides derived from different Mycobacterium leprae proteins improves sensitivity for immunodiagnosis of M. leprae infection.
Geluk A; van der Ploeg J; Teles RO; Franken KL; Prins C; Drijfhout JW; Sarno EN; Sampaio EP; Ottenhoff TH
Clin Vaccine Immunol; 2008 Mar; 15(3):522-33. PubMed ID: 18199740
[TBL] [Abstract][Full Text] [Related]
25. The role of macrophages in the lymphoproliferative response to Mycobacterium leprae in vitro.
Hirschberg H
Clin Exp Immunol; 1978 Oct; 34(1):46-51. PubMed ID: 373933
[TBL] [Abstract][Full Text] [Related]
26. Identification of a Mycobacterium leprae specific protein antigen(s) and its possible application for the serodiagnosis of leprosy.
Caldwell HD; Kirchheimer WF; Buchanan TM
Int J Lepr Other Mycobact Dis; 1979 Sep; 47(3):477-83. PubMed ID: 90666
[TBL] [Abstract][Full Text] [Related]
27. M. leprae and PPD-triggered T cell lines in tuberculoid and lepromatous leprosy.
Shankar P; Agis F; Wallach D; Flageul B; Cottenot F; Augier J; Bach MA
J Immunol; 1986 Jun; 136(11):4255-63. PubMed ID: 2422278
[TBL] [Abstract][Full Text] [Related]
28. Cellular and humoral immune responses to recombinant 65-kD antigen of Mycobacterium leprae in leprosy patients and healthy controls.
Ilangumaran S; Shanker Narayan NP; Ramu G; Muthukkaruppan VR
Clin Exp Immunol; 1994 Apr; 96(1):79-85. PubMed ID: 8149671
[TBL] [Abstract][Full Text] [Related]
29. Variation of in vitro lymphocyte responses to M. leprae antigen in borderline tuberculoid leprosy patients.
Bjune G
Int J Lepr Other Mycobact Dis; 1980 Mar; 48(1):30-40. PubMed ID: 6154019
[No Abstract] [Full Text] [Related]
30. Antigen specific macrophage-lymphocyte interaction in lepromatous leprosy.
Birdi TJ; Mistry NF; Mahadevan PR; Antia NH
J Clin Lab Immunol; 1984 Apr; 13(4):189-94. PubMed ID: 6376810
[TBL] [Abstract][Full Text] [Related]
31. Humoral and cellular immune reactivity to recombinant M. leprae antigens in HLA-typed leprosy patients and healthy controls.
Klatser PR; Janson AM; Thole JE; Buhrer S; Bos C; Soebono H; de Vries RR
Int J Lepr Other Mycobact Dis; 1997 Jun; 65(2):178-89. PubMed ID: 9251589
[TBL] [Abstract][Full Text] [Related]
32. Use of non-conventional antigen: M. habana in detecting M. leprae antibodies from leprosy patients and contacts in FLA-ABS test.
Rana NS; Gupta HP; Singh NB
Indian J Lepr; 1988 Oct; 60(4):593-9. PubMed ID: 3075637
[TBL] [Abstract][Full Text] [Related]
33. T cell epitopes on the 36K and 65K Mycobacterium leprae antigens defined by human T cell clones.
Van Schooten WC; Ottenhoff TH; Klatser PR; Thole J; De Vries RR; Kolk AH
Eur J Immunol; 1988 Jun; 18(6):849-54. PubMed ID: 2454825
[TBL] [Abstract][Full Text] [Related]
34. Phenolic glycolipid-I of Mycobacterium leprae induces general suppression of in vitro concanavalin A responses unrelated to leprosy type.
Prasad HK; Mishra RS; Nath I
J Exp Med; 1987 Jan; 165(1):239-44. PubMed ID: 3540178
[TBL] [Abstract][Full Text] [Related]
35. Demonstration of Mycobacterium leprae specific antigens in leprosy lesions using monoclonal antibodies.
Narayanan RB; Ramu G; Sinha S; Sengupta U; Malaviya GN; Desikan KV
Indian J Lepr; 1985; 57(2):258-64. PubMed ID: 2416852
[TBL] [Abstract][Full Text] [Related]
36. Analysis of cytokine production by Mycobacterium-reactive T cells. Failure to explain Mycobacterium leprae-specific nonresponsiveness of peripheral blood T cells from lepromatous leprosy patients.
Mutis T; Kraakman EM; Cornelisse YE; Haanen JB; Spits H; De Vries RR; Ottenhoff TH
J Immunol; 1993 May; 150(10):4641-51. PubMed ID: 8482851
[TBL] [Abstract][Full Text] [Related]
37. HLA and leprosy in the pre and postgenomic eras.
Geluk A; Ottenhoff TH
Hum Immunol; 2006 Jun; 67(6):439-45. PubMed ID: 16728267
[TBL] [Abstract][Full Text] [Related]
38. Detection of antigen in Nocardia caviae cross-reacting with mycobacterial antigen No. 21 in M. leprae using a lepromatous leprosy serum pool as antibody reagent.
Bjorvatn B; Kronvall G
Int J Lepr Other Mycobact Dis; 1980 Sep; 48(3):260-6. PubMed ID: 7002810
[TBL] [Abstract][Full Text] [Related]
39. The response of human B cells to Mycobacterium leprae. Identification of target antigens following polyclonal activation in vitro.
Mahon AC; Gebre N; Nurlign A
Int Immunol; 1990; 2(9):803-12. PubMed ID: 2279000
[TBL] [Abstract][Full Text] [Related]
40. Suppressive effect of circulating immune complexes from leprosy patients on the lymphocyte proliferation induced by M. leprae antigens in healthy responders.
Tyagi P; Patil SA; Girdhar BK; Katoch K; Sengupta U
Int J Lepr Other Mycobact Dis; 1992 Dec; 60(4):562-9. PubMed ID: 1299711
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
